Jinhai Medical Technology Limited announced that Mr. Li Bin is appointed as an executive director of the Company with effect from February 3, 2026. Mr. Li Bin is also appointed as the co-chairman of the Board. Mr. Li Bin, aged 52, has over 20 years of experience in enterprise and business management.
Mr. Li is the founder and the chairman of Shanghai Anbaida Investment Management Consulting Co., Ltd, a company focusing on sales of In Vitro Diagnosis diagnostic reagents, since April 2005, and he has been responsible for the formulating operation plan and investment strategies of the company. Mr. Li has also been a first-tier distributor of Roche In Vitro Diagnostics in Shanghai, leading the sales team in the area since April 2004. Mr. Li also served as senior management consultant of Jin Hai Holdings (HK) Limited, a company wholly-owned by Mr. Chen Guobao, our executive Director, between September 2025 and February 2026.
